Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Remicade Biosimilars OK’ed for Behcet’s-Associated Uveitis
April 23, 2020
- Ube Industries to Start Avigan Intermediate Supplies from July
April 23, 2020
- Myovant Files Relugolix for Advanced Prostate Cancer in US
April 23, 2020
- JCR to Develop 2 Mucopolysaccharidosis Drugs Using BBB-Penetrating Technology
April 23, 2020
- Japan Heading into Earnings Season amid Coronavirus Woes
April 22, 2020
- Shin Nippon Biomedical Joins AnGes Vaccine Development
April 22, 2020
- Drug Makers Restricting Nafamostat Supplies as Hopes Grow for Its Repurposing for COVID-19
April 22, 2020
- Ehime Univ., Sumitomo Dainippon Decipher Mechanism of Action of Malaria Vaccine Candidate
April 22, 2020
- Positive Data in Hand, Ono/Takeda to Seek 1st-Line RCC Nod for Opdivo/Cabometyx Combo
April 22, 2020
- Astellas Scoops Up UK's Mitochondria-Focused Biotech Nanna
April 22, 2020
- Sawai Curbing Shipments for 2 More Drugs after Nichi-Iko’s Massive Recalls
April 21, 2020
- Sumitomo Dainippon Chair Sees No Need for Further Consolidation among Japan Drug Makers
April 21, 2020
- Otsuka Grabs Japan Rights to Esperion’s Cholesterol Drug
April 21, 2020
- JCR Closes ArmaGen Buyout, Gaining IP Rights on Blood-Brain Barrier-Penetrating Technology
April 21, 2020
- Otsuka, Meiji Put Off Earnings Announcement amid COVID-19 Outbreak
April 21, 2020
- Japan Generic Makers’ New Grad Hiring Logs 1st Increase Since FY2016
April 20, 2020
- Some Drug Makers Rejuvenating Workforce by Boosting New Hires after Job Cuts: Jiho Survey
April 20, 2020
- Towa, Osaka Psychiatric Medical Center Pair Up on Novel Biomarker Research for AD
April 20, 2020
- Konica Minolta’s US Subsidiary to Launch PCR Testing Platform
April 20, 2020
- Takeda, Tohoku University Ink Joint Research Pact on Whole Genome Sequencing
April 20, 2020
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…